ERBB2 and breast cancer: We previously demonstrated that HER2-negative MCF-7 luminal breast cancer cells engineered to express higher amounts of the HER2 oncoprotein (MCF-7/HER2) present a significantly increased ability over MCF-7 parental cells to form mammospheres [58].